Information about SaveRxCanada.to
List of countries where we can ship Cladribine:
Latest news releases on Cladribine:
Cladribine, sold under the brand name Leustatin among others, is a medication used to treat hairy cell leukemia (HCL, leukemic reticuloendotheliosis) and B-cell ...
Cladribine official prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions, pharmacology and more.
Nu genoplives sclerose-præparatet cladribin, der i 2011 blev afvist pga. formodet kræftrisiko. Merck har netop indset ansøgning med nye solide langtidsdata i ryggen.
Eintrag zu Cladribine in der Human Metabolome Database (HMDB), abgerufen am 17. Oktober 2013. Einträge im NIH-Studienregister;
Leustatin (cladribine) Injection (also commonly known as 2-chloro-2΄-deoxy- β -D-adenosine) is a synthetic antineoplastic agent for continuous intravenous infusion.
Cladribine is also known as (Leustat®, Litak®). It is used to treat hairy cell leukaemia and a certain type of chronic lymphocytic leukaemia (CLL).
Mavenclad (cladribine) is a disease modifying drug treatment for relapsing remitting multiple sclerosis. Read more about Mavenclad in this A-Z entry.
The active substance in Mavenclad, cladribine, has a similar chemical structure to purine, one of the substances needed to make up the DNA. In the body, ...
Consumer information about the medication CLADRIBINE - INJECTION (Leustatin), includes side effects, drug interactions, recommended dosages, and storage information.
Drug was associated with a reduction in the annualized rate of relapse in both treatment groups [0.14 in the 3.5 mg group (a relative reduction of 57.6%) and 0.15 in ...